PharmaBiome
PrivateLast Round
Seed
Jul 8, 2020
Total Funding Raised
$2.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PharmaBiome is a biotechnology company that develops a drug development platform for targeted microbiome therapeutics to treat diseases caused by functional deficiencies in the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaBiome Comparables
Compare PharmaBiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MarvelBiome Inc. | 87% | |
| ImmunoBiome Inc. | 84% | |
| mbiomics GmbH | 81% |
PharmaBiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 8, 2020 | ||||
| Grant | Apr 23, 2020 | ||||
| Accelerator | Jan 16, 2020 | ||||
| Grant | May 22, 2019 | ||||
| Grant | Dec 1, 2017 | ||||
Grant | Jun 14, 2016 |
PharmaBiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| W.A. de Vigier Foundation | Grant |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 1915% MoM, from 46 to 927.
- May 3, 2025
Monthly visitors grew 31% MoM, reaching 1K.
PharmaBiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PharmaBiome's valuation, stock price, and market status.
Is PharmaBiome a public or private company?
PharmaBiome is a private company.
What is the current stock price of PharmaBiome?
PharmaBiome is a private company with no public stock price. No recent secondary market data is available.
How much is PharmaBiome worth (valuation)?
Valuation information for PharmaBiome is not publicly available.
Can I buy PharmaBiome stock?
PharmaBiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PharmaBiome's last funding round?
PharmaBiome's most recent funding round was Seed on July 8, 2020.
Who are the main investors in PharmaBiome?
Key investors in PharmaBiome include Horizon 2020, W.A. de Vigier Foundation, BaseLaunch, Venture Kick, Zurcher Kantonalbank.
Will PharmaBiome IPO soon?
No public IPO plans have been announced for PharmaBiome.
How can I track PharmaBiome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PharmaBiome's secondary market activity and sign up for updates.